Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 31, 2025
CMRA Market Cap
CMRA has a market cap or net worth of $31 as of January 8, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
31.00
Enterprise Value
n/a
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 21, 2020, CMRA's market cap has decreased from 132.69M to 31.00, a decrease of -100.00%. That is a compound annual growth rate of -95.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 31.00 | -99.50% |
| Dec 31, 2024 | 6.15K | -99.64% |
| Dec 29, 2023 | 1.69M | -93.08% |
| Dec 30, 2022 | 24.41M | -81.80% |
| Dec 30, 2021 | 134.14M | -1.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |